Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction
- PMID: 19332197
- DOI: 10.1016/j.ahj.2009.01.009
Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction
Abstract
Background: Kidney failure (stage 5 chronic kidney disease [CKD]) is an independent risk factor for stent thrombosis (ST). Moderate (stage 3-4) CKD and proteinuria are both associated with adverse cardiovascular events, including worse outcomes after myocardial infarction (MI). Whether moderate CKD and proteinuria increase the risk of ST after MI is not known. This study evaluated the risk of ST associated with moderate CKD and dipstick proteinuria.
Methods: We retrospectively analyzed clinical and laboratory data from 956 non-stage 5 CKD patients who were admitted with MI and received intracoronary stenting. Clinical follow-up was collected at 1 year for definite or probable ST, as well as for all-cause mortality, nonfatal MI or death, and target vessel revascularization or coronary artery bypass graft surgery.
Results: After adjustment for multiple clinical and biochemical covariates, patients with both estimated glomerular filtration rate (GFR) of 15 to 59 mL min(-1) 1.73 m(-2) and > or =30 mg/dL dipstick proteinuria had increased cumulative incidence of ST (hazard rate [HR] 3.69, 95% CI 1.54-8.89), all-cause mortality (HR 2.68, 95% CI 1.34-5.37), and nonfatal MI or death (HR 3.20, 95% CI 1.77-5.81) at 1 year. In addition, estimated GFR of 15 to 59 mL min(-1) 1.73 m(-2) was a significant independent predictor of ST (HR 2.61, 95% CI 1.33-5.10). Dipstick proteinuria > or =30 mg/dL was associated with a trend toward increased risk for all outcomes.
Conclusions: In an acute MI population, moderate CKD was identified as a novel prognostic marker for ST. In addition, patients with both decreased GFR and proteinuria had higher incidences of all-cause mortality and nonfatal MI or death than patients with either condition alone.
Similar articles
-
Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.Circulation. 2009 Oct 20;120(16):1577-84. doi: 10.1161/CIRCULATIONAHA.109.853648. Epub 2009 Oct 5. Circulation. 2009. PMID: 19805651 Clinical Trial.
-
Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation.Am Heart J. 2009 Jul;158(1):92-8. doi: 10.1016/j.ahj.2009.04.013. Am Heart J. 2009. PMID: 19540397
-
Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS).Am Heart J. 2005 Mar;149(3):512-9. doi: 10.1016/j.ahj.2004.10.010. Am Heart J. 2005. PMID: 15864241 Clinical Trial.
-
Effect of pravastatin on cardiovascular events in people with chronic kidney disease.Circulation. 2004 Sep 21;110(12):1557-63. doi: 10.1161/01.CIR.0000143892.84582.60. Epub 2004 Sep 13. Circulation. 2004. PMID: 15364796 Review.
-
Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.Catheter Cardiovasc Interv. 2009 Aug 1;74(2):323-32. doi: 10.1002/ccd.22017. Catheter Cardiovasc Interv. 2009. PMID: 19360858 Review.
Cited by
-
Serum Indoxyl Sulfate Associates with Postangioplasty Thrombosis of Dialysis Grafts.J Am Soc Nephrol. 2016 Apr;27(4):1254-64. doi: 10.1681/ASN.2015010068. Epub 2015 Oct 9. J Am Soc Nephrol. 2016. PMID: 26453609 Free PMC article.
-
Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor.Circulation. 2013 Jan 22;127(3):365-76. doi: 10.1161/CIRCULATIONAHA.112.118174. Epub 2012 Dec 25. Circulation. 2013. PMID: 23269489 Free PMC article.
-
Thrombosis in the uremic milieu--emerging role of "thrombolome".Semin Dial. 2015 Mar-Apr;28(2):198-205. doi: 10.1111/sdi.12255. Epub 2014 Jun 24. Semin Dial. 2015. PMID: 24962903 Free PMC article. Review.
-
The Impact of Renal Dysfunction on the Long Term Clinical Outcomes of Diabetic Patients Undergoing Percutaneous Coronary Intervention in the Drug-Eluting Stent Era.PLoS One. 2016 Jan 5;11(1):e0141846. doi: 10.1371/journal.pone.0141846. eCollection 2016. PLoS One. 2016. PMID: 26731526 Free PMC article.
-
Risk factors associated with intra-stent restenosis after percutaneous coronary intervention.Exp Ther Med. 2021 Oct;22(4):1141. doi: 10.3892/etm.2021.10575. Epub 2021 Aug 9. Exp Ther Med. 2021. PMID: 34504587 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous